Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT
Clinical trial NCT03288454 · COMPLETED
Trial details
- NCT number
- NCT03288454
- Sponsor
- Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-30
- Primary completion
- 2019-08-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.